128 related articles for article (PubMed ID: 21991856)
1. Plans and oncologists don't see eye to eye on prior authorization.
Reinke T
Manag Care; 2011 Sep; 20(9):14-6. PubMed ID: 21991856
[No Abstract] [Full Text] [Related]
2. What do physicians want from health plans?
Jessee WF
Manag Care; 2005 Mar; 14(3):14, 16. PubMed ID: 15825604
[No Abstract] [Full Text] [Related]
3. Balancing the policy with appropriate patient care.
Stefanacci RG
Manag Care; 2008 Jul; 17(7 Suppl 6):16-9. PubMed ID: 19093335
[TBL] [Abstract][Full Text] [Related]
4. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
[TBL] [Abstract][Full Text] [Related]
5. Managed care restrictions: barriers to product use in cancer care.
Fox LA
Am J Manag Care; 2013; 19(1 Spec No):SP24-5. PubMed ID: 23461469
[No Abstract] [Full Text] [Related]
6. CA study finds some challenges in Medicaid may be universal.
Public Sect Contract Rep; 1999 Oct; 5(10):158-60. PubMed ID: 10662126
[TBL] [Abstract][Full Text] [Related]
7. Impact of managed care on physicians' decisions to manipulate reimbursement rules: an explanatory model.
VanGeest J; Weiner S; Johnson T; Cummins D
J Health Serv Res Policy; 2007 Jul; 12(3):147-52. PubMed ID: 17716417
[TBL] [Abstract][Full Text] [Related]
8. Value-based reimbursement in oncology.
Kolodziej M; Hoverman JR
Am J Manag Care; 2012 May; 18(3 Spec No.):SP124-6. PubMed ID: 22642278
[No Abstract] [Full Text] [Related]
9. StatBite: Survey: Oncologists on Costs and Treatment.
J Natl Cancer Inst; 2009 Nov; 101(21):1443. PubMed ID: 19828872
[No Abstract] [Full Text] [Related]
10. 2005 TennCare survey validates physician concerns.
Zelizer G
Tenn Med; 2005 Nov; 98(11):514-5. PubMed ID: 16375082
[No Abstract] [Full Text] [Related]
11. Prevention and managed care.
Albrecht L
Tex Med; 1998 Nov; 94(11):70-4. PubMed ID: 9828686
[TBL] [Abstract][Full Text] [Related]
12. Insurers and oncologists forge a better cancer drug policy.
Butcher L
Manag Care; 2008 Apr; 17(4):28-30. PubMed ID: 18464570
[No Abstract] [Full Text] [Related]
13. Oncology and specialty drug management in managed care.
Navarro RP
Manag Care Interface; 2007 Sep; 20(9):25-6, 29. PubMed ID: 18161387
[No Abstract] [Full Text] [Related]
14. Provider Perspective on the Payer Perspective: What's in It for Me?
Stella PJ; Harrison KA
J Oncol Pract; 2015 May; 11(3):182-4. PubMed ID: 25804990
[No Abstract] [Full Text] [Related]
15. Assessment, authorization and access to medicaid managed mental health care.
Masland MC; Snowden LR; Wallace NT
Adm Policy Ment Health; 2007 Nov; 34(6):548-62. PubMed ID: 17929160
[TBL] [Abstract][Full Text] [Related]
16. Strategic viability of oncology carve-outs.
Fine A
Adm Radiol J; 1996 Sep; 15(9):12-3, 15-7. PubMed ID: 10162606
[No Abstract] [Full Text] [Related]
17. Plans that opted out. Many managed-care plans don't like how they're measured.
Comarow A
US News World Rep; 1998 Oct; 125(13):77-8. PubMed ID: 10186431
[No Abstract] [Full Text] [Related]
18. Stakeholder perceptions of quality in managed care plans.
Thompson JM
Manag Care Q; 2003; 11(2):12-21. PubMed ID: 12968438
[TBL] [Abstract][Full Text] [Related]
19. Managed care. Can lying be good medicine?
Lowes R
Med Econ; 2002 Oct; 79(19):86-8, 93-4. PubMed ID: 12407810
[No Abstract] [Full Text] [Related]
20. The search for managed care systems.
Waymack P
Health Manag Technol; 1999 Mar; 20(2):26-8. PubMed ID: 10346473
[No Abstract] [Full Text] [Related]
[Next] [New Search]
